Literature DB >> 5901510

Comparative fates of intravenously and orally administered aldosterone: evidence for extrahepatic formation of acid-hydrolyzable conjugate in man.

T Bledsoe, G W Liddle, A Riondel, D P Island, D Bloomfield, B Sinclair-Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5901510      PMCID： PMC292691          DOI： 10.1172/JCI105339

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  10 in total

1.  MODIFICATION OF ALDOSTERONE SECRETION AND ELECTROLYTE EXCRETION IN MAN BY A CHEMICAL INHIBITOR OF 18-OXIDATION.

Authors:  T BLEDSOE; D P ISLAND; A M RIONDEL; G W LIDDLE
Journal:  J Clin Endocrinol Metab       Date:  1964-08       Impact factor: 5.958

2.  ALDOSTERONE SECRETION AND METABOLISM IN HYPERTHYROIDISM AND MYXEDEMA.

Authors:  J A LUETSCHER; A P COHN; C A CAMARGO; A J DOWDY; A M CALLAGHAN
Journal:  J Clin Endocrinol Metab       Date:  1963-09       Impact factor: 5.958

3.  PURIFICATION, PARTIAL CHARACTERIZATION AND METABOLISM OF AN ACID LABILE CONJUGATE OF ALDOSTERONE.

Authors:  R H UNDERWOOD; J F TAIT
Journal:  J Clin Endocrinol Metab       Date:  1964-11       Impact factor: 5.958

4.  SPLANCHNIC EXTRACTION AND CLEARANCE OF ALDOSTERONE IN SUBJECTS WITH MINIMAL AND MARKED CARDIAC DYSFUNCTION.

Authors:  J F TAIT; B LITTLE; S A TAIT; C FLOOD; J BOUGAS
Journal:  J Clin Endocrinol Metab       Date:  1965-02       Impact factor: 5.958

5.  [RENAL CLEARANCE OF ALDOSTERONE AND ITS METABOLITE IN MAN].

Authors:  J GFELLER; W SIEGENTHALER
Journal:  Acta Endocrinol (Copenh)       Date:  1965-08

6.  CONJUGATION OF 1,2-3H-ALDOSTERONE IN HUMAN LIVER AND KIDNEYS AND RENAL EXTRACTION OF ALDOSTERONE AND LABELED CONJUGATES FROM BLOOD PLASMA.

Authors:  J A LUETSCHER; E W HANCOCK; C A CAMARGO; A J DOWDY; G W NOKES
Journal:  J Clin Endocrinol Metab       Date:  1965-05       Impact factor: 5.958

7.  The metabolism of aldosterone. II.

Authors:  T SANDOR; A LANTHIER
Journal:  Acta Endocrinol (Copenh)       Date:  1962-01

8.  The metabolism of aldosterone in normal subjects and in patients with hepatic cirrhosis.

Authors:  W S COPPAGE; D P ISLAND; A E COONER; G W LIDDLE
Journal:  J Clin Invest       Date:  1962-08       Impact factor: 14.808

9.  Double isotope derivative assay of aldosterone in biological extracts.

Authors:  B KLIMAN; R E PETERSON
Journal:  J Biol Chem       Date:  1960-06       Impact factor: 5.157

10.  Aldosterone metabolism in liver disease.

Authors:  R HURTER; J D NABARRO
Journal:  Acta Endocrinol (Copenh)       Date:  1960-02
  10 in total
  10 in total

1.  The renal tubular handling of aldosterone and its acid-labile conjugate.

Authors:  M T Scurry; L Shear; K G Barry
Journal:  J Clin Invest       Date:  1968-02       Impact factor: 14.808

Review 2.  Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: A comprehensive review.

Authors:  Lina Schiffer; Lise Barnard; Elizabeth S Baranowski; Lorna C Gilligan; Angela E Taylor; Wiebke Arlt; Cedric H L Shackleton; Karl-Heinz Storbeck
Journal:  J Steroid Biochem Mol Biol       Date:  2019-07-27       Impact factor: 4.292

3.  [Secretion, plasma concentration, distribution, metabolism and excretion of aldosterone in healthy and sick subjects].

Authors:  D Lommer; G Düsterdieck; J Jahnecke; P Vecsei; H P Wolff
Journal:  Klin Wochenschr       Date:  1968-07-15

4.  [Shortened biological half-life period of 1,2-3H-aldosterone in 3 nephretomized patients].

Authors:  J Möhring; W Siegenthaler; P Weidmann
Journal:  Klin Wochenschr       Date:  1968-01-01

5.  Distribution, conjugation, and excretion of labeled aldosterone in congestive heart failure and in controls with normal circulation: development and testing of a model with an analog computer.

Authors:  R A Cheville; J A Luetscher; E W Hancock; A J Dowdy; G W Nokes
Journal:  J Clin Invest       Date:  1966-08       Impact factor: 14.808

6.  A comparison of the metabolism of radioactive 17-isoaldosterone and aldosterone administered intravenously and orally to normal human subjects.

Authors:  C Flood; G Pincus; J F Tait; S A Tait; S Willoughby
Journal:  J Clin Invest       Date:  1967-05       Impact factor: 14.808

7.  The metabolism of orally and intravenously administered labeled aldosterone in pregnant subjects.

Authors:  J F Tait; B Little
Journal:  J Clin Invest       Date:  1969-11       Impact factor: 14.808

8.  Stimulation and suppression of aldosterone in plasma of normal man and in primary aldosteronism.

Authors:  R Horton
Journal:  J Clin Invest       Date:  1969-07       Impact factor: 14.808

Review 9.  Renal drug metabolism in humans: the potential for drug-endobiotic interactions involving cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT).

Authors:  Kathleen M Knights; Andrew Rowland; John O Miners
Journal:  Br J Clin Pharmacol       Date:  2013-10       Impact factor: 4.335

10.  Aldosterone glucuronidation by human liver and kidney microsomes and recombinant UDP-glucuronosyltransferases: inhibition by NSAIDs.

Authors:  Kathleen M Knights; Leanne K Winner; David J Elliot; Kushari Bowalgaha; John O Miners
Journal:  Br J Clin Pharmacol       Date:  2009-09       Impact factor: 4.335
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.